SEARCH

SEARCH BY CITATION

References

  • 1
    Yeo EJ, Wagner C. Tissue distribution of glycine N-methyltransferase, a major folate-binding protein of liver. Proc Natl Acad Sci U S A 1994; 91: 210214.
  • 2
    Kerr SJ. Competing methyltransferase systems. J Biol Chem 1972; 247: 42484252.
  • 3
    Chen YM, Shiu JY, Tzeng SJ, Shih LS, Chen YJ, Lui WY, et al. Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. Int J Cancer 1998; 75: 787793.
  • 4
    Liu HH, Chen KH, Shih YP, Lui WY, Wong FH, Chen YM. Characterization of reduced expression of glycine N-methyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies. J Biomed Sci 2003; 10: 8797.
  • 5
    Tseng TL, Shih YP, Huang YC, Wang CK, Chen PH, Chang JG, et al. Genotypic and phenotypic characterization of a putative tumor susceptibility gene, GNMT, in liver cancer. Cancer Res 2003; 63: 647654.
  • 6
    Chen SY, Lin JR, Darbha R, Lin P, Liu TY, Chen YM. Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway. Cancer Res 2004; 64: 36173623.
  • 7
    Aida K, Tawata M, Negishi M, Onaya T. Mouse glycine N-methyltransferase is sexually dimorphic and regulated by growth hormone. Horm Metab Res 1997; 29: 646649.
  • 8
    Mudd SH, Cerone R, Schiaffino MC, Fantasia AR, Minniti G, Caruso U, et al. Glycine N-methyltransferase deficiency: a novel inborn error causing persistent isolated hypermethioninaemia. J Inherit Metab Dis 2001; 24: 448464.
  • 9
    Augoustides-Savvopoulou P, Luka Z, Karyda S, Stabler SP, Allen RH, Patsiaoura K, et al. Glycine N -methyltransferase deficiency: a new patient with a novel mutation. J Inherit Metab Dis 2003; 26: 745759.
  • 10
    Sambrook PN, Champion GD, Browne CD, Cairns D, Cohen ML, Day RO, et al. Corticosteroid injection for osteoarthritis of the knee: peripatellar compared to intra-articular route. Clin Exp Rheumatol 1989; 7: 609613.
  • 11
    Anderson S. Shotgun DNA sequencing using cloned DNase I-generated fragments. Nucleic Acids Res 1981; 9: 30153027.
  • 12
    Dierlamm J, Wlodarska I, Michaux L, La SR, Zeller W, Mecucci C, et al. Successful use of the same slide for consecutive fluorescence in situ hybridization experiments. Genes Chromosomes Cancer 1996; 16: 261264.
  • 13
    Lee CM, Chen SY, Lee YC, Huang CY, Chen YM. Benzo[a]pyrene and glycine N-methyltransferse interactions: gene expression profiles of the liver detoxification pathway. Toxicol Appl Pharmacol 2006; 214: 126135.
  • 14
    Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 422: 4352.
  • 15
    Luka Z, Capdevila A, Mato JM, Wagner C. A glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme. Transgenic Res 2006; 15: 393397.
  • 16
    Mato JM, Corrales FJ, Lu SC, Avila MA. S-Adenosylmethionine: a control switch that regulates liver function. FASEB J 2002; 16: 1526.
  • 17
    Lu SC, Tsukamoto H, Mato JM. Role of abnormal methionine metabolism in alcoholic liver injury. Alcohol 2002; 27: 155162.
  • 18
    James SJ, Melnyk S, Pogribna M, Pogribny IP, Caudill MA. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 2002; 132: S2361S2366.
  • 19
    Zhu BT. On the mechanism of homocysteine pathophysiology and pathogenesis: a unifying hypothesis. Histol Histopathol 2002; 17: 12831291.
  • 20
    Schanche JS, Schanche T, Ueland PM, Montgomery JA. Inactivation and reactivation of intracellular S-adenosylhomocysteinase in the presence of nucleoside analogues in rat hepatocytes. Cancer Res 1984; 44: 42974302.
  • 21
    Schwahn BC, Chen Z, Laryea MD, Wendel U, Lussier-Cacan S, Genest J Jr, et al. Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency. FASEB J 2003; 17: 512514.
  • 22
    Wagner C, Briggs WT, Cook RJ. Inhibition of glycine N-methyltransferase activity by folate derivatives: implications for regulation of methyl group metabolism. Biochem Biophys Res Commun 1985; 127: 746752.
  • 23
    Jencks DA, Mathews RG. Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium. J Biol Chem 1987; 262: 24852493.
  • 24
    Solans A, Estivill X, de la Luna S. Cloning and characterization of human FTCD on 21q22.3, a candidate gene for glutamate formiminotransferase deficiency. Cytogenet Cell Genet 2000; 88: 4349.
  • 25
    Shin YS. Glycogen storage disease: clinical, biochemical, and molecular heterogeneity. Semin Pediatr Neurol 2006; 13: 115120.
  • 26
    Voet D, Voet JG. Glycogen metabolism. In: Biochemistry. 3rd ed. Hoboken, NJ: John Wiley & Sons; 2004: 626656.
  • 27
    Raben N, Nagaraju K, Lee E, Kessler P, Byrne B, Lee L, et al. Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem 1998; 273: 1908619092.
  • 28
    Chou JY, Matern D, Mansfield BC, Chen YT. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med 2002; 2: 121143.
  • 29
    Chen LY, Shieh JJ, Lin B, Pan CJ, Gao JL, Murphy PM, et al. Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter. Hum Mol Genet 2003; 12: 25472558.
  • 30
    Rowling MJ, McMullen MH, Schlinske KL. Vitamin A and its derivatives induce hepatic glycine N-methyltransferase and hypomethylation of DNA in rats. J Nutr 2002; 132: 365369.
  • 31
    Rowling MJ, Schalinske KL. Retinoic acid and glucocorticoid treatment induce hepatic glycine N-methyltransferase and lower plasma homocysteine concentrations in rats and rat hepatoma cells. J Nutr 2003; 133: 33923398.
  • 32
    Nieman KM, Rowling MJ, Garrow TA, Schalinske KL. Modulation of methyl group metabolism by streptozotocin-induced diabetes and all-trans-retinoic acid. J Biol Chem 2004; 279: 4570845712.
  • 33
    Nieman KM, Schelinske KL. Modulation of methyl group and homocysteine methylation metabolism by insulin treatment in diabetes rats. FASEB J 2006; 20: A607.
  • 34
    Bannasch P, Hacker HJ, Klimek F, Mayer D. Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. Adv Enzyme Regul 1984; 22: 97121.
  • 35
    Hacker HJ, Moore MA, Mayer D, Bannasch P. Correlative histochemistry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in the rat liver. Carcinogenesis 1982; 3: 12651272.
  • 36
    Limmer J, Fleig WE, Leupold D, Bittner R, Ditschuneit H, Beger HG. Hepatocellular carcinoma in type I glycogen storage disease. HEPATOLOGY 1988; 8: 531537.